Our findings showed a significant decrease (p = 0.049) in the expression levels of CD86 (MFI 579.3) in classical monocytes of Alzheimer’s disease patients compared to those with other dementias (MFI 597.1). This evidence concerns the gene CD86 and early-onset autosomal dominant Alzheimer disease.